Clinical Trial Update: A Study of Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer

View source ↗

Summary

This clinical trial update describes a tumor-agnostic MRD (minimal residual disease) detection study in stage III colorectal cancer, using ctDNA, sponsored by S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer, MRD | Status: NOT_YET_RECRUITING